Satter Investment Management
12
54M
4
2
0.67
4
- Stages of investment
- Areas of investment
Summary
The company was established in North America in United States. The main office of represented VC is situated in the Chico.
Considering the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year. The important activity for fund was in 2014. The higher amount of exits for fund were in 2018. Deals in the range of 10 - 50 millions dollars are the general things for fund. Opposing the other organizations, this Satter Investment Management works on 4 percentage points more the average amount of lead investments.
The current fund was established by Muneer A. Satter.
The fund has exact preference in some founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Annexon Biosciences, Aerpio Pharmaceuticals, Akebia Therapeutics. Among the most popular fund investment industries, there are Life Science, Health Care.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Satter Investment Management, startups are often financed by Venture Investors, Novartis Venture Fund, Triathlon Medical Venture Partners. The meaningful sponsors for the fund in investment in the same round are Novartis Venture Fund, Venture Investors, Triathlon Medical Venture Partners. In the next rounds fund is usually obtained by Novartis Venture Fund, New Enterprise Associates, Athenian Venture Partners.
Investments analytics
Analytics
- Total investments
- 12
- Lead investments
- 2
- Exits
- 4
- Follow on index
- 0.67
- Investments by industry
- Biotechnology (12)
- Therapeutics (12)
- Health Care (11)
- Health Diagnostics (6)
- Life Science (6) Show 1 more
- Investments by region
-
- United States (12)
- Peak activity year
- 2014
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 14
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Annexon Biosciences | 01 Jul 2020 | Biotechnology, Health Care, Health Diagnostics, Life Science, Therapeutics | Late Stage Venture | 100M | United States, California, South San Francisco |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.